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A rare case of bilateral optic neuritis and Guillain–Barré syndrome post-Mycoplasma 
pneumoniae infection  
 
 
Abstract 
Neurological complications are the most commonly encountered extra-pulmonary 
manifestation of infection with Mycoplasma pneumoniae.  Here we report the case of a 39-
year-old female who was admitted with acute onset, bilateral visual loss coinciding with 
ascending numbness. Clinical examination, neurological imaging and nerve conduction 
studies revealed a syndrome of bilateral optic neuritis and acute inflammatory 
demyelinating polyneuropathy. Serological testing confirmed recent exposure to 
Mycoplasma pneumoniae. The patient did not experience any clinical benefit with pulsed 
intravenous methylprednisolone but demonstrated marked clinical and radiological 
improvement following five days of plasma exchange. This report will explore the diagnostic 
and therapeutic approach to patients with neuro-ophthalmological and neurological 
complications of Mycoplasma pneumoniae infection in addition to discussing previously 
encountered cases.  
Case report 
A 39-year-old Afro-Caribbean female was admitted urgently to our neurological department 
from the local ophthalmic hospital casualty department, having presented with acute-onset 
bilateral visual loss. Ten days preceding her admission, she had noted a frontal headache, 
followed by bilateral eye pain and gradual reduction in visual clarity over the subsequent 
five days.   Upon initial assessment visual acuity (VA) was nil perception of light (NPL) in 
either eye. Pupillary reflexes were absent. She had bilateral swelling of the optic discs with 
splinter haemorrhages (figure 1a). There was bilateral globe tenderness but no pain on eye 
movements.  Assessment of her visual fields demonstrated large central scotomas bilaterally 
(figure 1b). The remainder of cranial nerve examination was normal. 
She also noted sensory disturbance in her fingers and toes. Examination revealed reduction 
in both light-touch and pin-prick in a length dependent fashion in both the upper and lower 
limbs. Reflexes were symmetrical and present bilaterally, although were later lost in the 
lower limbs.  
MRI of the brain and orbits on admission showed bilateral enhancement and enlargement 
of the intra-orbital portion of the optic nerves (figure 3a). The reminder of the brain 
parenchyma were normal. PET-CT of the whole body did not show any pathological uptake.  
Electrophysiological investigation demonstrated a motor predominant acquired distal 
demyelinating polyneuropathy.   
Cerebrospinal fluid showed protein of 0.21g/L, white cell count of 4, negative culture and 
cytology. Routine blood tests were normal.  HIV, aquaporin-4; anti-neuronal antibodies and 
other auto-antibodies were negative.  Mycoplasma pneumoniae serology showed a titre of 
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1:20480, highly suspicious of acute infection. Subsequent convalescent sera confirmed that 
this was a recent exposure and on further questioning the patient recalled a mild upper 
respiratory tract infection two weeks earlier in the community characterised by a dry cough 
and headache. Mycoplasma was not isolated from the CSF, and CSF Mycoplasma PCR was 
negative. 
A diagnosis of bilateral optic neuritis and acute inflammatory demyelinating polyneuropathy 
secondary to Mycoplasma pneumoniae infection was made. 
The mycoplasma infection was treated on admission with an oral course of clarithromycin 
(seven days). The patient was treated on admission with six doses of 1g intravenous 
methylprednisolone on consecutive days without clinical improvement. We then proceeded 
immediately to plasma exchange, completing five courses over five days. This produced 
rapid clinical improvement of visual acuity and gradual improvement of her sensory 
symptoms. Upon discharge of the patient, the VA in the right eye was 6/18 and the VA in 
the left eye was 6/9. She was discharged on an oral taper of prednisolone over 1 month 
starting at 1 mg/kg. 
Repeat imaging two weeks after completion of plasma exchange demonstrated radiological 
resolution of the bilateral optic neuritis (figure 3b) and repeat nerve conduction studies 
showed marked improvement of the polyneuropathy. Fundal photography eight weeks 
post-treatment demonstrated bilateral optic disc pallor (figure 2a). 
Eight months later, upon review in the outpatient clinic, the patient had a VA of 6/5 in the 
left eye and a VA of 6/12 in the right eye.  Despite improvement in the diameter of the 
scotomas, there were persisting visual field deficits in the right & left eyes (figure 2b).  She 
has not had any relapse of her optic neuritis following complete tapering of oral steroid 
therapy. She had no remaining symptoms of her previous polyneuropathy. 
 
Discussion 
Mycoplasma pneumoniae is a commonly encountered pathogen that is often associated 
with infection of the respiratory system and produces a highly variable clinical phenotype, 
ranging from a mild upper respiratory tract infection to a severe pneumonia1.  In addition to 
its respiratory manifestations it can also give rise to numerous extra-pulmonary 
manifestations, particularly neurological1.   
Neurological complications have been reported to occur in between 0.1- 7% of patients 
infected with Mycoplasma pneumoniae, typically occurring between 2 and 14 days after 
initial respiratory symptoms2.  These have been widely reported in the paediatric 
population1-3. Central nervous system (CNS) manifestations include: encephalitis, 
meningoencephalitis, aseptic meningitis, transverse myelitis, cerebellar ataxia, 
choreoathetosis, ischaemic stroke and syndrome of inappropriate anti-diuretic hormone. 
Peripheral nervous system manifestations are less commonly described but include: optic 
neuritis, cranial nerve palsies, Guillain–Barré Syndrome, polyradiculitis and peripheral 
neuropathy (box 1)1-5.  
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The pathogenesis of the neurological complications of Mycoplasma infection is poorly 
understood and is a source of debate1, 6. It has been postulated that there may be two 
distinct mechanisms of mycoplasma-induced neurological disease: first, the direct result of 
mycoplasma invasion into the CSF7 and second, a systemic immune-mediated response to 
infection, with CNS sequelae.  The latter mechanism fits best with the clinical presentation 
of our patient. 
The diagnosis of Mycoplasma pneumoniae can prove challenging. Historically, cold 
agglutinins were used to aid the diagnosis of Mycoplasma pneumoniae infection. Cold 
agglutinins are produced 1-2 weeks after infection in 50% of patients and may persist for 
several weeks but due to their poor sensitivity and specificity they are now considered 
obsolete in making a diagnosis.  Microbial culture is technically demanding, and seldom 
successful in routine medical practice. Diagnosis of Mycoplasma infection is primarily 
achieved through a consistent clinical presentation that coincides with positive serological 
testing, such as passive agglutination, complement fixation and ELISA. Serological tests for 
anti-Mycoplasma antibody represent the most common method for retrospective diagnosis 
of Mycoplasma infections but they depend on convalescent sera for confirmation and false 
positive results from cross reactivity are a problem1,2.  Seroconversion is defined as a four-
fold increase in titre between acute and convalescent sera, or a single high anti-Mycoplasma 
complement fixation antibody titre of >1:1281.  These criteria were both met in our patient. 
A combination of PCR and serology is recommended for accurate diagnosis especially for 
patients with neurological and other extra-pulmonary manifestations 1,2.  
The concomitant occurrence of bilateral optic neuritis and Guillain–Barré Syndrome post-
Mycoplasma infection has been reported on four previous occasions in the published 
literature; however, in three of the four cases the onset of an acute inflammatory 
demyelinating polyneuropathy (AIDP) preceded the onset of bilateral optic neuritis9,10. 
Ginesta et al.8 described a similar case of bilateral ON preceding AIDP, however, in contrast 
to our case, their patient demonstrated an AIDP with predominantly motor symptoms. In all 
four cases, excellent motor recovery and partial visual recovery was achieved with the use 
of immunotherapy (two cases treated with intravenous immunoglobulins, one with plasma 
exchange and one with intravenous steroids). Whilst our patient did not improve with the 
use of intravenous steroid therapy, the use of plasma exchange produced rapid recovery of 
visual acuity and resolution of the sensory symptoms.  
The role of antimicrobials in the treatment of neurological manifestations of Mycoplasma 
infection remains controversial whilst the mechanism of disease is unclear. If Mycoplasma 
infection is directly responsible for the pathology, then antibiotic treatment would be 
recommended.  Antibiotic treatment recommendations also need to take in to account CSF 
bioavailability. If the mechanism is immune-mediated then it is less clear whether 
antimicrobial therapy is appropriate.10 1, particularly after the acute illness has resolved1.  In 
practice patients such as ours are treated urgently with antibiotic and immune therapy. 
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Conclusion 
We report a rare case of bilateral optic neuritis in association with acute inflammatory 
demyelinating polyneuropathy secondary to Mycoplasma pneumoniae with severe neuro-
ophthalmological deterioration and a poor initial response to intravenous steroid therapy; 
thus requiring escalation to plasma exchange with good response.   
The most effective treatment protocol is not known, and good clinical response has been 
seen with steroids and intravenous immunoglobulin therapy. However, given our patient’s 
dramatic response to plasma exchange in the absence of any improvement with steroid 
therapy we believe this should be considered early in patients presenting with this clinical 
syndrome, in order to minimise the potential for long term neurological and neuro-
ophthalmic damage. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key messages 
• M. pneumoniae can lead to a diverse range of neurological 
manifestations and should be considered, particularly in cases 
with an infectious prodrome 
• We report a case of bilateral optic neuritis and acute 
inflammatory demyelinating polyneuropathy post-M. 
pneumoniae infection 
• The infection can be difficult to diagnose but serological 
testing and PCR are the most commonly utilised methods 
• Early immunotherapy and antibiotic therapy are essential. 
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Figure 1a: Fundal imaging demonstrating bilateral optic disc swelling with splinter haemorrhages in both 
right and left eyes  
Figure 1b: Visual fields obtained via Goldman perimetry on admission demonstrating bilateral central 
scotomas  
Figure 1  
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Figure 2a: Fundal imaging 2 months following initial treatment demonstrating bilateral optic disc pallor  
Figure 2b: Visual fields assessed via gold perimetry at 8 months following completion of plasma exchange 
demonstrating improvement in the size of the bilateral central scotomas  
Figure 2  
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Figure 3a: Bilateral enlargement and post-gadolinium enhancement of the intra-orbital and intra-canalicular 
portions of the optic nerve  
Figure 3b: Following plasma exchange, marked improvement of the swelling of both optic nerves with 
minimal enhancement seen post-gadolinium administration  
 
Figure 3  
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